Isha Ambani Piramal Launches 'Being Breast-Aware: What Every Woman Must Know' Book at India Breast Meeting 2024

Smt. Isha Ambani Piramal launched, “Being Breast-Aware: What Every Woman Must Know,” a book written by Dr. Vijay Haribhakti, Chair, Onco Sciences, Sir HN Reliance Foundation Hospital, in an effort to raise awareness about breast health. This book is part of the global breast cancer convention, India Breast Meeting 2024, which is being arranged by the Sir HN Reliance Foundation Hospital.

“The fight against breast cancer is a journey of compassion and resilience, where every act of awareness and every gesture of support becomes a beacon of hope & healing for patients and their families. With the inaugural ‘India Breast Meeting 2024’, we have tried to bring together the knowledge and experience of experts from around the world. We hope this expands the scope and quality of care for breast cancer patients. My sincere appreciation and gratitude to the entire team at Sir H.N. Reliance Foundation Hospital for spearheading this initiative and constantly raising the bar for top quality patient care and support.” said Smt. Isha Ambani Piramal, Director, Reliance Industries Limited.

Breast cancer has emerged as the leading human cancer and the most prevalent cancer among women worldwide and in India. In 2022, 2.3 million women were diagnosed with breast cancer and 670,000 died from the disease globally. This means that breast cancer is the most diagnosed cancer in women worldwide, accounting for 1 in 4 cancer cases. It’s also the second most common cancer across all genders, and the leading cause of cancer-related deaths in women. The book aims to give precise information by medical experts and serve as a tool to help in prevention, early detection and optimal care for breast cancer, which remain crucial to an improved survival rate as well as quality of life.

“To address the concerning rise in breast cancer, Sir H. N. Reliance Foundation Hospital also offers the “One Stop Breast Clinic,” aimed at helping any woman with a possible or proven disease of the breast get a comprehensive evaluation, diagnosis and treatment pathway within two hours.